Both in Pharmaceuticals
Cogent Biosciences vs Ligand Pharmaceuticals
Over the past year COGT returned +100.4% and LGND returned +63.9%; their daily moves had a correlation of 0.25.
COGT +100.4% LGND +63.9%Growth of $1, one year, split-adjusted
| Metric | COGT | LGND |
|---|---|---|
| Price | $31.06 | $313.52 |
| Market cap | $5.39B | $6.27B |
| Today | +4.47% | +2.12% |
| 1 month | +0.6% | +2.2% |
| 6 months | −16.0% | +35.0% |
| Year to date | −12.6% | +65.8% |
| 1 year | +90.6% | +63.9% |
| Revenue growth (YoY) | — | −31.8% |
| Gross margin | — | 83.7% |
| Net margin | — | −36.2% |
| P/E (TTM) | — | 121.9× |
| Price / sales | — | 24.7× |
| Net cash | $568.8M | -$653.3M |
| Dividend yield | — | — |
| Volatility (60d) | 41.2% | 29.7% |
| Short % of float | 13.2% | 13.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).